{
  "question_stem": {
    "en": "A 38-year-old man comes to the office with headaches, loss of libido, and erectile dysfunction for the last 3 months. The patient has no chronic medical conditions and takes no prescription or over-the-counter medications. He does not use tobacco, alcohol, or illicit drugs. Vital signs are normal. The examination is notable for peripheral vision loss, bilateral gynecomastia, and soft testes without masses. Laboratory evaluation shows normal serum prolactin, normal β-hCG, low serum LH, and low serum testosterone. Which of the following is the most likely mechanism for this patient's gynecomastia?",
    "zh": "一名38岁的男性因头痛、性欲减退和勃起功能障碍来到诊所就诊，这些症状已持续3个月。患者无慢性病史，未服用处方药或非处方药。他不吸烟、不饮酒，也不吸食违禁药物。生命体征正常。体格检查显示周围视野丧失、双侧男性乳房发育症和柔软的睾丸，无肿块。实验室评估显示血清催乳素正常、β-hCG正常、血清LH低、血清睾酮低。以下哪项最可能是该患者男性乳房发育症的机制？"
  },
  "question": {
    "en": "Which of the following is the most likely mechanism for this patient's gynecomastia?",
    "zh": "以下哪项最可能是该患者男性乳房发育症的机制？"
  },
  "options": {
    "A": {
      "en": "Decreased systemic clearance of estrogen",
      "zh": "雌激素的全身清除率降低"
    },
    "B": {
      "en": "Defective androgen receptor function",
      "zh": "雄激素受体功能缺陷"
    },
    "C": {
      "en": "Enzymatic defect in the testosterone biosynthetic pathway",
      "zh": "睾酮生物合成途径的酶缺陷"
    },
    "D": {
      "en": "Excessive estrogen production in the testes",
      "zh": "睾丸中雌激素产生过多"
    },
    "E": {
      "en": "Persistent aromatization of adrenal estrogen precursors",
      "zh": "肾上腺雌激素前体的持续芳香化"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "This patient's headaches and peripheral vision loss (ie, bitemporal hemianopsia) suggest a pituitary mass with compression of the optic chiasm {{exhibit_1}}. In addition, he has features of hypogonadism, including decreased libido, erectile dysfunction, testicular atrophy, and a low circulating testosterone level; his low LH level confirms secondary (central) hypogonadism.\n\nSecondary hypogonadism is common in patients with pituitary masses. Potential etiologies include the following:\n\nHigh prolactin levels from a prolactin-secreting adenoma (prolactinoma) can suppress secretion of GnRH, leading to decreased LH secretion and lower testosterone production\nNon-prolactin-secreting tumors can disrupt the inhibitory dopaminergic regulation of prolactin secretion, leading to hyperprolactinemia and (usually mild) hypogonadism\nDirect compression of gonadotrope cells with loss of LH secretion (independent of prolactin effect), which is likely in this patient with a normal prolactin level\nGynecomastia is the abnormal growth of male breast tissue, typically due to an increased estrogen/testosterone ratio. This patient has low testosterone, but production of estrogen precursors (eg, androstenedione, dehydroepiandrosterone [DHEA], DHEA sulfate) continues uninterrupted in the zona reticularis of the adrenal cortex. These steroid hormones are subsequently aromatized to estrogens in peripheral tissues. When testosterone levels are normal, the inhibitory effect of testosterone prevents breast growth, but when testosterone is low, the adrenal-derived estrogens can produce significant gynecomastia.\n\n(Choice A) Estrogen is cleared primarily in the liver. Patients with cirrhosis commonly develop gynecomastia due to decreased clearance of estrogen along with increased production and aromatization of estrogen precursors. However, this patient has no risk factors for cirrhosis (eg, alcohol use), and his bitemporal hemianopsia suggests a pituitary etiology.\n\n(Choice B) Androgen receptor defects typically present at birth with a female phenotype or ambiguous genitalia (with 46,XY karyotype), although some variants (partial androgen insensitivity syndrome) may present in adulthood with gynecomastia and undervirilization (eg, decreased facial and pubic hair). However, androgen production is unaffected, and testosterone levels would be normal to high.\n\n(Choice C) Testosterone biosynthetic defects generally present at birth or during development with abnormal genitalia and/or undervirilization in males. Biochemical testing shows primary hypogonadism (ie, low testosterone, high LH).\n\n(Choice D) Estrogen is synthesized in the testes by the aromatization of androgens, producing high local concentrations. However, this patient has decreased testicular testosterone production, so subsequent estrogen synthesis would also be low.\n\nEducational objective:\nThe adrenal cortex produces estrogen precursors (eg, androstenedione, dehydroepiandrosterone [DHEA], DHEA sulfate), which are subsequently aromatized to estrogens in peripheral tissues. In men with hypogonadism (low testosterone), the resulting elevation in the estrogen/testosterone ratio can produce gynecomastia. {{exhibit_2}} {{exhibit_3}} {{exhibit_4}}",
    "zh": "该患者的头痛和周围视野丧失（即，双颞侧偏盲）提示垂体肿瘤压迫视交叉 {{exhibit_1}}。此外，他具有性腺功能减退的特征，包括性欲减退、勃起功能障碍、睾丸萎缩和循环睾酮水平低；其低LH水平证实为继发性（中枢性）性腺功能减退。\n\n继发性性腺功能减退在垂体肿瘤患者中很常见。潜在病因包括：\n\n来自泌乳素分泌腺瘤（泌乳素瘤）的高泌乳素水平可抑制促性腺激素释放激素（GnRH）的分泌，导致LH分泌减少和睾酮产生减少。\n\n非泌乳素分泌肿瘤可破坏多巴胺能对泌乳素分泌的抑制性调节，导致高泌乳素血症和（通常轻度）性腺功能减退。\n\n直接压迫促性腺激素细胞导致LH分泌丧失（不依赖于催乳素的作用），这在该患者中很可能，其催乳素水平正常。\n\n男性乳房发育症是男性乳腺组织的异常生长，通常是由于雌激素/睾酮比值升高所致。该患者睾酮水平低，但肾上腺皮质网状带中雌激素前体（例如，雄烯二酮、脱氢表雄酮[DHEA]、DHEA硫酸盐）的产生持续不断。这些类固醇激素随后在周围组织中芳香化为雌激素。当睾酮水平正常时，睾酮的抑制作用可防止乳房生长，但当睾酮水平低时，肾上腺衍生的雌激素可产生显著的男性乳房发育症。\n\n(选项A) 雌激素主要在肝脏中清除。肝硬化患者通常由于雌激素清除率降低以及雌激素前体产生和芳香化增加而发生男性乳房发育症。然而，该患者没有肝硬化的危险因素（例如，饮酒），并且他的双颞侧偏盲提示垂体病因。\n\n(选项B) 雄激素受体缺陷通常在出生时表现为女性表型或性器官模糊（具有46,XY核型），尽管某些变异（部分雄激素不敏感综合征）可在成年时表现为男性乳房发育症和男性化不足（例如，面部和阴毛减少）。然而，雄激素产生不受影响，睾酮水平将正常或高。\n\n(选项C) 睾酮生物合成缺陷通常在出生或发育期间表现为男性生殖器异常和/或男性化不足。生化检测显示原发性性腺功能减退（即，睾酮低，LH高）。\n\n(选项D) 雌激素在睾丸中通过雄激素的芳香化合成，产生高局部浓度。然而，该患者睾丸睾酮产生减少，因此随后的雌激素合成也会降低。\n\n教育目标：\n肾上腺皮质产生雌激素前体（例如，雄烯二酮、脱氢表雄酮[DHEA]、DHEA硫酸盐），这些前体随后在周围组织中芳香化为雌激素。在患有性腺功能减退症（低睾酮）的男性中，由此导致的雌激素/睾酮比值升高可产生男性乳房发育症。{{exhibit_2}} {{exhibit_3}} {{exhibit_4}}"
  },
  "summary": {
    "en": "This question tests knowledge of the pathophysiology of gynecomastia, specifically in the context of secondary hypogonadism caused by a pituitary mass. It requires understanding of hormone production pathways and the estrogen/testosterone ratio. \n\nThe key to solving this question is recognizing the signs and symptoms of a pituitary mass (headaches, vision loss) and secondary hypogonadism (low LH, low testosterone). Then, consider the mechanisms that can lead to gynecomastia in this setting, focusing on the role of adrenal estrogen precursors.",
    "zh": "此问题考察对男性乳房发育症的病理生理学的了解，特别是在垂体肿瘤引起的继发性性腺功能减退的背景下。它需要了解激素产生途径和雌激素/睾酮比值。\n\n解决此问题的关键是识别垂体肿瘤的体征和症状（头痛、视力丧失）以及继发性性腺功能减退（低LH，低睾酮）。然后，考虑在这种情况下可能导致男性乳房发育症的机制，重点关注肾上腺雌激素前体的作用。"
  },
  "tags": "Gynecomastia; Hypogonadism; Pituitary mass; Estrogen; Testosterone; Aromatization; Endocrinology; Neurology; Vision loss",
  "category": "Endo",
  "question_id": "19002",
  "has_exhibits": true,
  "exhibit_count": 4,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg",
    "image3.jpg",
    "image4.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Endo 23\\19002",
  "extracted_at": "2025-11-05T14:04:17.195001",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T17:39:18.826025",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}